ArticleFrontiers in cell and developmental biology2025
Inflammation centered muscle signature of sarcopenia from postmenopausal women in Shanghai China.
Article in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Sarcopenia reflects age-related failure of muscle maintenance and regeneration, with chronic low-grade inflammation disrupting the satellite cell niche. Validated tissue biomarkers that connect inflammaging to clinical phenotypes remain limited. We sought to define an inflammation-centered muscle transcriptomic signature in postmenopausal women from Shanghai China and to assess its association with case-control status and muscle phenotypes. Methods: We prospectively enrolled 20 women undergoing femoral fracture surgery including sarcopenia (n = 8) and controls (n = 12). Vastus lateralis biopsies underwent RNA sequencing. Differentially expressed genes were identified and intersected with inflammation-associated genes from GeneCards. Random-forest models prioritized a minimal marker set. Discrimination was assessed with receiver operating characteristic analysis. Associations with appendicular lean mass, handgrip strength and calf circumference were tested. Results: We detected 301 differentially expressed genes enriched for p53, MAPK, TNF and NF-κB signaling together with ubiquitin-mediated proteolysis and cellular senescence. Intersection with the inflammation catalogue yielded 22 candidates that separated cases from controls by unsupervised clustering. Random-forest ranking nominated a five-gene panel JUN, SOCS3, CP, PTEN and C4B that showed strong single-gene discrimination with areas under the curve from 0.830 to 0.906. Higher expression of these genes was inversely associated with muscle quantity and strength. Discussion: This work is a pilot study that delineates an inflammation-associated transcriptomic phenotype of sarcopenia in postmenopausal women. These markers nominate testable inflammatory pathways and provide a rationale for validation studies designed to determine whether non-invasive surrogates or larger cohorts can substantiate their translational relevance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.